AYRWF Overview

• Ayr Wellness Developments: Ayr Wellness is advancing its debt restructuring while launching its first indoor cultivation facility in Florida, which will produce premium cannabis and create around 100 jobs.

• Vireo Growth Acquisition: Vireo Growth has acquired $91 million in senior secured convertible notes from Schwazze for $62 million, aiming to gain control over Schwazze's assets and reshape its operations.

• Tilray's Expansion: Tilray has expanded into Panama through a joint venture, receiving a medical cannabis license to cultivate, manufacture, and distribute cannabis, enhancing its global presence.

• Enveric and Algernon Updates: Enveric Biosciences has strengthened its intellectual property with a new patent for neuroplastogenic compounds, while Algernon Pharmaceuticals has rebranded to Algernon Health, focusing on Alzheimer's diagnostics and establishing neuroimaging clinics.

• Debt Restructuring Announcement: AYR Wellness Inc. is advancing its debt restructuring process through a foreclosure sale, as outlined in the Restructuring Support Agreement with senior noteholders, with a public auction scheduled for November 10, 2025.

• Operational Continuity: Despite the restructuring, AYR Wellness will continue to operate its businesses and provide products and services during the transition of asset ownership to the successful bidder.

• Financial Reporting: AYR Wellness Inc. has filed its unaudited interim condensed consolidated financial statements for Q1 2025, which are available for review on SEDAR+ and the SEC's EDGAR system. Shareholders are encouraged to review these documents for insights into the company's performance and liquidity.

• Non-GAAP Measures: The company utilizes non-GAAP measures like "Adjusted EBITDA" and "Adjusted Gross Profit" to provide additional transparency regarding its financial performance, which may not be fully captured by GAAP measures. These metrics are intended to highlight trends in the company's core operations.

AYR Wellness Inc. Secures Funding for Restructuring

• Bridge Credit Agreement: AYR Wellness Inc. has entered into a definitive senior secured bridge term loan agreement, providing up to $50 million in funding to support ongoing operations and facilitate a restructuring plan announced on July 30, 2025.
• Loan Structure: The agreement includes multiple-draw senior secured term loans, with Tranche A and Tranche B loans designated for specific purposes, including working capital and the wind-down of non-core assets.

Purpose and Use of Funds

• Funding Allocation: Proceeds from Tranche A will be used for working capital, corporate expenses, and costs related to the Sale Transaction, while Tranche B will fund the court-supervised wind-down of non-core assets.
• Budget Approval: The use of funds is contingent upon approval from lenders holding a majority of the commitments under the Bridge Facility.

Loan Terms and Conditions

• Interest and Maturity: The loans carry an interest rate of 14.0% per annum, with Tranche A maturing either 60 days post-closing or by November 16, 2025, and Tranche B maturing by February 19, 2026.
• Covenants and Defaults: The agreement includes various covenants, such as maintaining cannabis licenses and a minimum liquidity requirement of $17.5 million, with events of default including payment defaults and insolvency events.

Future Implications

• Conversion to Take-Back Facility: Upon the effective date of the Sale Transaction, all outstanding principal and accrued interest under the Bridge Facility will convert into a new senior secured "take-back" term facility.
• Forward-Looking Statements: The company acknowledges potential risks and uncertainties that could affect the anticipated outcomes related to the restructuring and future financial performance.

Company Overview

• AYR Wellness Profile: AYR Wellness is a leading multi-state cannabis operator in the U.S., with over 90 licensed retail locations across several states, offering a diverse range of cannabis products and consumer brands.

• Biorestorative Therapies Earnings Report: Biorestorative Therapies, Inc. (BRTX) reported a quarterly loss of $0.3 per share, better than the expected loss of $0.41, and achieved revenues of $0.3 million, surpassing estimates by 51.50%. The company has shown mixed performance in earnings estimate revisions, currently holding a Zacks Rank #3 (Hold).

• Industry Outlook and Comparisons: The Medical - Biomedical and Genetics industry is ranked in the bottom 43% of Zacks industries, impacting stock performance expectations. Ayr Wellness Inc. (AYRWF), another company in the sector, is anticipated to report a loss with declining revenue projections for the upcoming quarter.

• AYR Wellness Restructuring Agreement: AYR Wellness Inc. has entered into a Restructuring Support Agreement with senior noteholders to facilitate the orderly transition of its business, including asset sales and a bridge loan facility of up to $50 million to support operations during the restructuring process.

• Liquidation Plans: Following the asset sale auction, AYR will initiate court-supervised liquidation proceedings in British Columbia and state-level wind-down processes in the U.S., with proceeds distributed among secured creditors according to legal priorities.